Clinical Trial Update: Functional Magnetic Resonance Imaging - Synthetic Aperture Magnetometry (fMRI-SAM) and Alzheimer's Disease [NA]

View source ↗

Summary

The clinical trial NCT00412048 evaluating functional MRI-SAM in Alzheimer's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Alzheimer's Disease | NA | Status: WITHDRAWN